한글목차

Drug Discovery 정보학 시장 규모는 2025년 39억 8,000만 달러에서 2026년부터 2034년까지 CAGR 9.1%로 성장하여 2034년에는 87억 1,000만 달러에 달할 것으로 예측됩니다.

신약개발 프로세스의 복잡성과 효율적인 데이터 관리 솔루션의 필요성으로 인해 Drug Discovery 정보학 시장은 괄목할만한 성장세를 보이고 있습니다. 신약정보학은 의약품 개발 라이프사이클 전반에 걸쳐 생물학적, 화학적 데이터의 분석, 시각화, 관리를 촉진하는 다양한 도구와 기술을 포괄하고 있습니다. 제약사들이 조사개발에 박차를 가하면서 협업과 데이터 통합을 강화하는 정보학 솔루션에 대한 수요가 증가할 것으로 예상되며, 이 시장은 견조한 성장세를 보일 것으로 전망됩니다.

또한, 정보 기술 분야의 발전은 신약 정보학 시장 내 혁신을 촉진하고 있습니다. 인공지능(AI), 머신러닝(ML), 빅데이터 분석의 통합은 연구자들이 방대한 데이터세트를 분석하는 방식을 변화시켜 잠재적인 신약 후보물질을 효율적으로 식별할 수 있도록 돕고 있습니다. 이러한 기술은 예측 모델링, 가상 스크리닝, 데이터 마이닝을 촉진하고, 신약개발과 관련된 시간과 비용을 크게 줄일 수 있습니다. 신약 정보학의 새로운 조사 방법 및 응용 분야 연구가 진행됨에 따라 의약품 개발의 효율성과 혁신성에 대한 기대감을 바탕으로 시장은 더욱 확대될 것으로 예상됩니다.

또한, 연구기관과 제약사 간 공동 연구와 데이터 공유의 중요성이 높아지는 것도 Drug Discovery 정보학의 트렌드를 형성하고 있습니다. 이해관계자들이 공동 연구의 가치를 인식함에 따라 플랫폼 간 데이터 통합 및 공유를 지원하는 정보학 솔루션에 대한 수요가 증가할 것으로 예상됩니다. 이러한 추세는 데이터의 투명성과 접근성이 신약개발에 필수적인 오픈 사이언스 개념의 맥락에서 특히 중요한 의미를 지닙니다. 신약 정보학 시장이 계속 진화하는 가운데, 기술 발전, 공동 연구 모델, 데이터 기반 의사결정에 대한 집중의 조합이 향후 시장 궤도를 형성하는 데 중요한 역할을 할 것입니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 Drug Discovery 정보학 시장 : 용도별

제5장 세계의 Drug Discovery 정보학 시장 : 기능별

제6장 세계의 Drug Discovery 정보학 시장 : 최종사용자별

제7장 세계의 Drug Discovery 정보학 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Drug Discovery Informatics Market size is expected to reach USD 8.71 Billion in 2034 from USD 3.98 Billion (2025) growing at a CAGR of 9.1% during 2026-2034.

The drug discovery informatics market is experiencing significant growth, driven by the increasing complexity of drug development processes and the need for efficient data management solutions. Drug discovery informatics encompasses a range of tools and technologies that facilitate the analysis, visualization, and management of biological and chemical data throughout the drug development lifecycle. As pharmaceutical companies seek to accelerate their research and development efforts, the demand for informatics solutions that enhance collaboration and data integration is expected to rise, positioning this market for robust expansion.

Moreover, advancements in informatics technologies are propelling innovation within the drug discovery informatics market. The integration of artificial intelligence (AI), machine learning (ML), and big data analytics is transforming the way researchers analyze vast datasets, enabling more efficient identification of potential drug candidates. These technologies facilitate predictive modeling, virtual screening, and data mining, significantly reducing the time and cost associated with drug discovery. As research continues to explore new methodologies and applications in drug discovery informatics, the market is likely to expand further, driven by the promise of enhanced efficiency and innovation in drug development.

Additionally, the growing emphasis on collaboration and data sharing among research institutions and pharmaceutical companies is shaping the drug discovery informatics landscape. As stakeholders recognize the value of collaborative research efforts, the demand for informatics solutions that support data integration and sharing across platforms is likely to increase. This trend is particularly relevant in the context of open science initiatives, where transparency and accessibility of data are essential for advancing drug discovery efforts. As the drug discovery informatics market continues to evolve, the combination of technological advancements, collaborative research models, and a focus on data-driven decision-making will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Drug Discovery
• Drug Development

By Function

• Sequencing and Target Data Analysis
• Library and Database Preparation
• Docking, Molecular Modelling
• Others

By End User

• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organizations
• Others

COMPANIES PROFILED

• Certara, Boehringer Ingelheim International GmbH, Infosys Ltd, Charles River Laboratories, Collaborative Drug Discovery, Inc, Eurofins DiscoverX Products, Jubliant Biosys, Selvita, Novo Informatics Pvt Ltd, ChemAxon Ltd, Albany Molecular Research Inc, Oracle, Accenture, Agilent Technologies, Inc, Illumina, Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY FUNCTION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Function
• 5.2. Sequencing and Target Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Library and Database Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Docking, Molecular Modelling Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Function
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Function
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Function
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Function
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Function
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG DISCOVERY INFORMATICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Certara
  • 9.2.2 Boehringer Ingelheim International GmbH
  • 9.2.3 Infosys Ltd
  • 9.2.4 Charles River Laboratories
  • 9.2.5 Collaborative Drug DiscoveryInc
  • 9.2.6 Eurofins DiscoverX Products
  • 9.2.7 Jubliant Biosys
  • 9.2.8 Selvita
  • 9.2.9 Novo Informatics Pvt. Ltd
  • 9.2.10 ChemAxon Ltd
  • 9.2.11 Albany Molecular Research Inc
  • 9.2.12 Oracle
  • 9.2.13 Accenture
  • 9.2.14 Agilent TechnologiesInc
  • 9.2.15 IlluminaInc